Trademark Overview
On Thursday, May 2, 2024, a trademark application was filed for INLEXZO with the United States Patent and Trademark Office. The USPTO has given the INLEXZO trademark a serial number of 98531370. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, May 2, 2024. This trademark is owned by Johnson & Johnson. The INLEXZO trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, alloimmune diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, hematological diseases, urological diseases, maternal fetal disorders, digital ulcers
Medical apparatus for introducing pharmaceutical preparations into the human body; implantable medical device for introducing pharmaceutical preparations into the human body; implantable drug delivery device